+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Some implications of current therapy in leukaemia



Some implications of current therapy in leukaemia



South African Medical Journal 48(37): 1573-1576




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 044359691

Download citation: RISBibTeXText

PMID: 4527979


Related references

Hyperleukocytosis in new patients with acute lymphoblastic leukaemia Current implications in a background of modern induction therapy. Blood 98(11 Part 2): 219b-220b, November 16, 2001

Estimation of current leukaemia-free survival following donor lymphocyte infusion therapy for patients with leukaemia who relapse after allografting: Application of a multistate model. Statistics in Medicine 19(21): 3005-3016, 15 November, 2000

Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy. Bmc Medical Research Methodology 11(): 140-140, 2012

Treatment of acute lymphoblastic leukaemia: effect of "prophylactic" therapy against central nervous system leukaemia. Report ot the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood. British Medical Journal 2(5863): 381-384, 1973

Leukaemia and its therapy Implications for the anaesthesiologist. Anaesthesist 41(8): 438-447, 1992

Chromatin modification, leukaemia and implications for therapy. British Journal of Haematology 118(3): 714-727, 2002

Chronic lymphocytic leukaemia: current first-line therapy. Internal Medicine Journal 39(1): 44-48, 2009

Neuropsychological and educational sequelae following cranial irradiation for childhood acute lymphoblastic leukaemia Implications for current treatment protocols. Journal of Clinical & Experimental Neuropsychology 15(1): 82, 1993

The current status of therapy for adult T-cell leukaemia-lymphoma in Japan. Leukemia & Lymphoma 44(4): 611-618, 2003

The Use of Nanocarriers in Acute Myeloid Leukaemia Therapy: Challenges and Current Status. Current Pharmaceutical Biotechnology 17(1): 30-41, 2016

Prognostic factors in chronic lymphocytic leukaemia and their implications for therapy. Clinics in Haematology 6(1): 203-222, 1977

Current Perspectives on the Use of Growth Factors in the Therapy of Acute Myeloid Leukaemia; Malignancy. Hematology 5(3): 189-203, 2001

Targeted therapy in acute myeloid leukaemia: current status and future directions. Expert Opinion on Investigational Drugs 18(4): 433-455, 2009

Treatment of acute leukaemia in adults: comparison of steroid and mercaptopurine therapy, alone and in conjunction. Second report to the Medical Research Council of the Working Party on the evaluation of different methods of therapy in leukaemia. British Medical Journal 1(5500): 1383-1389, 1966